US FDA approves Genmab-AbbVie’s blood cancer therapy
The U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker Genmab’s blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said on Friday. The drug, epcoritamab, to be sold under the brand name Epkinly was developed to treat a type of advanced large…